Catherine Wood's VCYT Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 3.89 M shares of Veracyte, Inc. (VCYT) worth $163.67 M, representing 1.09% of the portfolio. First purchased in 2016-Q4, this long-term strategic position has been held for 37 quarters.
Based on 13F filings, Catherine Wood has maintained a strategic position in VCYT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2020, adding 2.01 M shares. Largest reduction occurred in Q3 2024, reducing 1.89 M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Veracyte (VCYT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Veracyte (VCYT) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -578,228 | Reduce 12.95% | 3.89 M | $42.10 |
| Q3 2025 | +665,686 | Add 17.52% | 4.47 M | $34.33 |
| Q2 2025 | -139,213 | Reduce 3.53% | 3.8 M | $27.03 |
| Q1 2025 | -264,649 | Reduce 6.30% | 3.94 M | $29.65 |
| Q4 2024 | -716,794 | Reduce 14.57% | 4.2 M | $39.60 |
| Q3 2024 | -1.89 M | Reduce 27.73% | 4.92 M | $34.04 |
| Q2 2024 | -233,486 | Reduce 3.32% | 6.81 M | $21.67 |
| Q1 2024 | -612,820 | Reduce 8.00% | 7.04 M | $22.16 |
| Q4 2023 | +62,011 | Add 0.82% | 7.66 M | $27.51 |
| Q3 2023 | -234,700 | Reduce 3.00% | 7.59 M | $22.33 |
| Q2 2023 | -580,814 | Reduce 6.91% | 7.83 M | $25.47 |
| Q1 2023 | +108,865 | Add 1.31% | 8.41 M | $22.30 |
| Q4 2022 | -781,122 | Reduce 8.60% | 8.3 M | $23.73 |
| Q3 2022 | +225,118 | Add 2.54% | 9.08 M | $16.60 |
| Q2 2022 | +100,221 | Add 1.14% | 8.86 M | $17.58 |
| Q1 2022 | +533,743 | Add 6.49% | 8.76 M | $27.57 |
| Q4 2021 | +1.24 M | Add 17.79% | 8.22 M | $41.20 |
| Q3 2021 | +290,938 | Add 4.35% | 6.98 M | $46.45 |
| Q2 2021 | -928,024 | Reduce 12.18% | 6.69 M | $39.98 |
| Q1 2021 | -1.41 M | Reduce 15.62% | 7.62 M | $53.75 |
| Q4 2020 | +2.01 M | Add 28.62% | 9.03 M | $48.94 |
| Q3 2020 | +1.95 M | Add 38.61% | 7.02 M | $32.49 |
| Q2 2020 | +1.8 M | Add 55.05% | 5.06 M | $25.90 |
| Q1 2020 | +477,423 | Add 17.12% | 3.27 M | $24.31 |
| Q4 2019 | +205,638 | Add 7.96% | 2.79 M | $27.92 |
| Q3 2019 | -453,855 | Reduce 14.95% | 2.58 M | $24.00 |
| Q2 2019 | -422,420 | Reduce 12.21% | 3.04 M | $28.51 |
| Q1 2019 | -34,182 | Reduce 0.98% | 3.46 M | $25.02 |
| Q4 2018 | -447,549 | Reduce 11.36% | 3.49 M | $12.58 |
| Q3 2018 | +180,145 | Add 4.79% | 3.94 M | $9.55 |
| Q2 2018 | +949,365 | Add 33.77% | 3.76 M | $9.34 |
| Q1 2018 | +1.41 M | Add 100.48% | 2.81 M | $5.56 |
| Q4 2017 | +1.4 M | Add 0.00% | 1.4 M | $6.53 |
| Q2 2017 | +103,157 | Add 172.32% | 163,020 | $8.33 |
| Q1 2017 | +14,512 | Add 32.00% | 59,863 | $9.19 |
| Q4 2016 | +45,352 | Add 0.00% | 45,351 | $7.74 |
Catherine Wood's Veracyte Investment FAQs
Catherine Wood first purchased Veracyte, Inc. (VCYT) in Q4 2016, acquiring 45,351 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Veracyte, Inc. (VCYT) for 37 quarters since Q4 2016.
Catherine Wood's largest addition to Veracyte, Inc. (VCYT) was in Q4 2020, adding 9,027,827 shares worth $441.82 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 3,887,547 shares of Veracyte, Inc. (VCYT), valued at approximately $163.67 M.
As of the Q4 2025 filing, Veracyte, Inc. (VCYT) represents approximately 1.09% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Veracyte, Inc. (VCYT) was 9,081,363 shares, as reported at the end of Q3 2022.